Backgrounds: The number of appendectomies and cholecystectomies performed is gradually increasing worldwide. An increasing incidence of colorectal cancer (CRC) after appendectomy and cholecystectomy has been reported, but the location of tumors in certain segments of the colon and rectum after appendectomy and cholecystectomy is still uncertain. We aimed to evaluate the distribution of the locations of colorectal cancer after appendectomy and/or cholecystectomy in patients who underwent CRC surgery. Methods: We reviewed the medical records of patients who had undergone CRC surgery between 2015 and 2017 for the presence of previous appendectomy/cholecystectomy. Data were collected from the Colorectal Data Base of the University of Szeged, Department of Surgery. Results: Surgery for CRC was performed in 640 patients during the study period. Data of 604 patients were analyzed. Appendectomy was performed in 100 patients (16.6%), cholecystectomy in 65 (10.8%), and both interventions in 18 (3%) before the CRC surgery. Out of those patients who underwent appendectomy alone, 92 (92%) had undergone appendectomy more than 10 years before the CRC surgery. Also in these 100 patients, the prevalence of right-sided colon cancer (CC) was 35% (n = 35), in comparison with the prevalence among the 504 other patients (20.4%, n = 103). The prevalence of right-sided CC among patients who underwent cholecystectomy alone was 36.9% (n = 24), in comparison with 21.2% (n = 114) of the 539 other patients. Conclusions: A significant left to right side shift in CRC was noted among patients who had previously undergone appendectomy/cholecystectomy. Because right-sided CC has a worse prognosis, the role of incidental appendectomy and routine cholecystectomy seems that need re-evaluation.
1 July 2017 in European Journal of Surgical Oncology
We aimed to investigate the contribution of co-translational protein aggregation to the chemotherapy resistance of tumor cells. Increased co-translational protein aggregation reflects altered translation regulation that may have the potential to buffer transcription under genotoxic stress. As an indicator for such an event, we followed the cytoplasmic aggregation of RPB1, the aggregation-prone largest subunit of RNA polymerase II, in biopsy samples taken from patients with invasive carcinoma of no special type. RPB1 frequently aggregates co-translationally in the absence of proper HSP90 chaperone function or in ribosome mutant cells as revealed formerly in yeast. We found that cytoplasmic foci of RPB1 occur in larger sizes in tumors that showed no regression after therapy. Based on these results, we propose that monitoring the cytoplasmic aggregation of RPB1 may be suitable for determining—from biopsy samples taken before treatment—the effectiveness of neoadjuvant chemotherapy.
8 December 2022 in Pathology and Oncology Research
Background: During the last decade, one of the most important treatment options for locally advanced, potencially resectable rectal tumours was neoadjuvant chemoradiotherapy (CRT) followed by surgery.Methods: Effects of the neoadjuvant treatment on surgical outcomes were retrospectively analysed in 185 patients with stage T2–T4 and N0–2, resectable rectal tumour among two patient groups defined by radiosensitizer agents. Group 1 (n = 94) involved radiotherapy (RT) with 50.4 Gy total dose (25 × 1.8 Gy + 3 × 1.8 Gy tumour bed boost), and intravenous 5-fluorouracil (5-FU) (350 mg/m2) with leucovorin (20 mg/m2) on the 1–5 and 21–25 days, while Group 2 (n = 91) RT and orally administrated capecitabine (daily 2 × 825 mg/m2) on RT days. Surgery was carried out after 8–10 weeks. Side effects, perioperative complications, type of surgery, number of removed regional lymph nodes, resection margins and tumour regression grade (TRG) were analysed.Results: More favourable side effects were observed in Group 2. Despite the same rate of diarrhoea (Group 1 vs. Group 2: 54.3% vs. 56.0%), Grade 2–3 diarrhoea ratio was lower (p = 0.0352) after capecitabine (Group 2). Weight loss occurred in 17.0% and 2.2% (p = 0.00067), while nausea and vomiting was described in 38.3% and 15.4% (p = 0.00045) with 5-FU treatment and capecitabine respectively. Anaemia was observed in 33.0% and 22.0% (p = 0.0941). Complete tumour regression occurred in 25.3% after oral- and 13.8% after intravenous treatment (p = 0.049). Ratio of sphincter preservation was higher with laparoscopy than open surgery (72.3% vs. 39.7%) (p = 0.00001).Conclusion: The study confirms advantages of neoadjuvant chemoradiotherapy with oral capecitabine for rectal tumours, such as more favourable side effect profile and overall clinical outcome, with increased rate of complete tumour regression.
1 April 2020 in European Journal of Surgical Oncology
Introduction: Zenker's diverticulum, located in the pharyngo-esophageal region, is the most common type of pulsion type diverticulum of the oesophagus. Besides traditional transcervical diverticulum resection and pharyngoesophageal myotomy, endoscopic diverticulostomy is also an accepted treatment option. In our clinical trial we compared advantages and disadvantages of the two methods. Methods: Our retrospective study involves 26 operative cases (19 male, 7 female) of Zenker's diverticulum between 2000 and 2011. Our operative methods involved an open technique (OT)-diverticulum resection from a cervical approach together with myotomy and an endoscopic technique (ET)-transpharyngeal diverticulostomy with the help of an endoscopic suturing machine. Between the above mentioned period we operated 11 cases with the OT and 15 cases with the ET. We compared the results of both methods according to operative time, start of oral nutrition, postoperative complications, hospitalization, and recurrence rate. Results: Average diverticulum size did not show differences among the two groups: OT: 4.9cm (3–7cm), ET: 5.06cm (3–14cm). Operative time was significantly shorter in the ET group (ET-OT: 42.28min. vs. 97.4min. p<0.05). In both cases oral nutrition was started after negative contrast enhanced swallow X-ray findings, which were performed on the 5–6th (4–7th) day-OT and 3rd (1–5th) day-ET. Average hospital stay was 10.72 (8–14) days-OT and 6.73 (5–10) days-ET. There were no postoperative complications in the cases of ET, 1 case of aspiraton pneumonia occured after performing OT. Controll contrast enhanced swallow X-ray did not show cases of contrast leaking or suture insufficiency in either groups. In both groups mortality was 0%. Short- and long term follow-ups showed 3 cases of partial recurrence of previous complaints- previously all 3 patients received ET diverticulostomy for the treatment of 3cm large diverticula. In these cases a second operation was performed. OT cases showed no postoperative recurrence. Conclusion: Although shorter operative time, earlier start of oral nutrition and shorter hospitalization were observed in cases of ET, traditional OT is still eligible for the operative treatment of Zenker's diverticulum. Performing OT is advised as a second operation after recurrence, or after insufficient ET and in the cases of <3cm diverticula.